CardiacSense logo — First medical watch for long-term continuous vital signs mon...

CardiacSense

First medical watch for long-term continuous vital signs monitoring and real time arrhythmia detection over the wrist

Founded 2009 Israel Israel 40 employees Series A Biotechnology, Digital Health +3

General Information

Company Name CardiacSense
Founded Year 2009
Location Israel Israel
Employees 40
Industries Biotechnology, Digital Health, Hardware +2
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with CardiacSense. To contact CardiacSense, visit cardiacsense.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CardiacSense compare?

A PDF of CardiacSense and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CardiacSense soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CardiacSense

CardiacSense is a pioneering company that has developed the first medical watch for long-term continuous vital signs monitoring and real-time arrhythmia detection over the wrist. With a focus on revolutionizing healthcare, the company's CE and FDA-cleared device offers an impressive 99.2% sensitivity and specificity in continuously detecting A-Fib and various arrhythmias through PPG and/or ECG. Additionally, the smartwatch tracks respiration rate for the well-being of CHF/COPD patients and measures Oxygen Saturation, with plans to introduce cuff-less Absolute Blood Pressure clearance in Q2/2024.

Founded in 2009 and headquartered in Israel, CardiacSense's innovative approach caters to Remote Patient Monitoring (RPM), Chronic Care Management (CCM), and Telemedicine. The company's state-of-the-art sensors ensure precision and reliability, making it a perfect solution for the future of healthcare. The recent Series A investment on 01 May 2022 signifies a promising trajectory for CardiacSense, solidifying its position at the intersection of HealthTech, Cardiac Monitoring, TeleHealth, and Innovation in Healthcare. With a mission where innovation meets compassion, CardiacSense is poised for a healthier future.

Business keywords: Wearable Health Technology, Medical Wearables, Continuous Vital Signs Monitoring, Remote Patient Monitoring, Chronic Care Management, Telemedicine, HealthTech Innovation, Cardiac Monitoring, Arrhythmia Detection, Heart Rate Variability, Respiratory Rate Monitoring, Oxygen Saturation Monitoring, Blood Pressure Monitoring, Healthcare Diagnostics, Medical Device Innovation

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed -
01 May 2022
Series A Undisclosed -
01 Feb 2021
Venture Series Unknown Undisclosed -
31 Mar 2019
Grant Undisclosed -
01 Jan 2019
Seed Undisclosed -
01 Mar 2018
Seed Undisclosed -
01 May 2017
Seed Undisclosed -
03 May 2016
Grant Undisclosed -
01 Dec 2014
Grant Undisclosed -
01 Jan 2014
Seed Undisclosed -
01 Jan 2010

CardiacSense Alternatives & Competitors

View All Alternatives
CardiacSense vs
Cardiomo
Cardiomo United States

Cardiomo provides wearable remote cardiac monitoring using a proprietary AI engine to enable early w...

Grant
4 employees
AI, Hardware
CardiacSense vs
Waire Health Ltd
Waire Health Ltd United Kingdom

Delivering the next generation of Continuous Vital Signs Monitoring technology.

Venture round
3 employees
Digital Health, Health Care
CardiacSense vs
Vitls Inc
Vitls Inc United States

The world’s most intelligent vital signs platform with innovative wearable for continuous, remote pa...

Seed
5 employees
Hardware, Health Care

FAQ About CardiacSense

First medical watch for long-term continuous vital signs monitoring and real time arrhythmia detection over the wrist
CardiacSense was founded in 2009.
CardiacSense is headquartered in Israel.
CardiacSense operates in Biotechnology, Digital Health, Hardware, Health Care and Medical Devices. Its work centres on Wearable Health Technology, Medical Wearables, Continuous Vital Signs Monitoring and Remote Patient Monitoring.
CardiacSense has approximately 40 employees.
CardiacSense has completed 10 funding rounds. The latest funding stage is Series A.
Top alternatives and competitors to CardiacSense include Cardiomo, Waire Health Ltd, Vitls Inc, BIOSTRAP, Eupnea. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CardiacSense and Cardiomo are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CardiacSense, https://bouncewatch.com/company/cardiacsense, updated 3 March 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes